ClinicalTrials.gov
public full text
Public Domain
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
The purpose of this study is to determine the relationship between two types of cell signals, type I interferon (IFN) and tumor necrosis factor (TNF), in psoriatic skin prior to and during treatment with etanercept and correlate that information with the degree of the improvement in the psoriasis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- TNFR2 is expressed by a discrete subset of epidermal T cells with an IL-17 gene signature during psoriasis#305595
- Data Management and Sharing Plan for: Antiviral and immunomodulatory effects of interferon lambda in the skin#212505
- Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma#867718
- Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis#837808
- T Cell Function in Chronic Idiopathic Urticaria#871779
Record · ID 883989
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive